Sinopharm Group Co. Ltd (X2S) — Cash Flow Reinvestment Rate
Sinopharm Group Co. Ltd (X2S) has a Cash Flow Reinvestment Rate of 0.01x as of December 2022, reinvesting €767.58 Million (capex €654.69 Million plus investments €112.89 Million) from operating cash flow of €52.39 Billion. Explore X2S capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sinopharm Group Co. Ltd Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Sinopharm Group Co. Ltd across 13 annual periods. Also explore Sinopharm Group Co. Ltd assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Sinopharm Group Co. Ltd (2013–2025)
Year-by-year capital reinvestment analysis for Sinopharm Group Co. Ltd. For live market cap and broader valuation context, see Sinopharm Group Co. Ltd market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.12x | €1.64 Billion | €14.14 Billion | €1.62 Billion | ▼ -32.2% |
| 2024 | 0.17x | €1.97 Billion | €11.55 Billion | €1.97 Billion | ▲ +24.4% |
| 2023 | 0.14x | €2.36 Billion | €17.17 Billion | €2.34 Billion | ▲ +32.2% |
| 2022 | 0.10x | €2.18 Billion | €20.96 Billion | €2.13 Billion | ▼ -53.5% |
| 2021 | 0.22x | €2.08 Billion | €9.31 Billion | €2.07 Billion | ▲ +29.9% |
| 2020 | 0.17x | €1.92 Billion | €11.15 Billion | €1.90 Billion | ▲ +39.4% |
| 2019 | 0.12x | €2.32 Billion | €18.78 Billion | €2.21 Billion | ▼ -87.9% |
| 2018 | 1.02x | €3.74 Billion | €3.65 Billion | €3.24 Billion | ▲ +18.9% |
| 2017 | 0.86x | €2.76 Billion | €3.21 Billion | €2.12 Billion | ▲ +168.3% |
| 2016 | 0.32x | €2.97 Billion | €9.26 Billion | €1.36 Billion | ▲ +321.2% |
| 2015 | 0.08x | €1.02 Billion | €13.41 Billion | €1.02 Billion | ▼ -71.4% |
| 2014 | 0.27x | €1.48 Billion | €5.56 Billion | €1.45 Billion | ▲ +10.3% |
| 2013 | 0.24x | €1.19 Billion | €4.94 Billion | €1.13 Billion | — |